marwan g. fakih, md, describes the role of kras inhibitors in colorectal cancer
Published 5 years ago • 123 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:08
marwan g. fakih, md, on why amg 510 seems promising in colorectal and lung cancers
-
1:04
marwan g. fakih, md, on combining regorafenib checkpoint inhibition in advanced crc
-
1:14
marwan g. fakih, md, on whether kras amplification predicts resistance to egfr therapies
-
1:14
dr. fakih on ras mutations in colon cancer
-
1:05
marwan fakih, md, considers implications from the amg 510 trial
-
1:08
dr. fakih on the safety profile of amg 510 in kras g12c-mutated crc
-
1:42
marwan g. fakih, md, regarding outcomes from the amg 510 study
-
1:24
meet medical oncologist marwan g. fakih, m.d. | city of hope
-
4:33
my colorectal cancer symptoms
-
1:01:28
real talk. my journey with stage 4 colon cancer
-
59:34
michael levin & mustafa djamgoz | bioelectricity and cancer
-
1:22
marwan fakih, md, discusses the phase 1 trial evaluating amg 510 in solid tumors
-
1:39
dr. fakih on the use of regional therapy in colorectal cancer
-
7:12
esmo 2017 - marwan fakih interview
-
3:42
role of rebiopsy and ctdna testing at progression of mcrc
-
1:59
dr. fakih on future directions in crc
-
12:04
sotorasib plus panitumumab in refractory kras g12c-mutated colorectal cancer
-
1:30
dr. fakih on advances in liver-directed therapies in crc
-
2:18
asco 2019: marwan fakih, m.d.
-
0:06
signs and symptoms of colorectal cancer
-
3:13
colorectal cancer | causes and prevention 💪🏻